CRT-832 EVEREST II REALISM - A Continued Access Study To Evaluate The Safety And Effectiveness Of The MitraClip Device: Demographics And Procedural Outcomes
Laura Mauri(Brigham and Women's Hospital), Ted Feldman(Edwards Lifesciences (United States)), Saibal Kar(Bakersfield Heart Hospital), Vivek Rajagopal(Piedmont Atlanta Hospital), Chad Rammohan(El Camino Hospital), Tanvir Bajwa(Aurora Health Care), D. Scott Lim(University of Virginia), James Hermiller(St. Vincent Hospital), Ramon Quesada(Baptist Hospital of Miami), Paul Grayburn(Heart Hospital Baylor Plano)
Cited by 2
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k